

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * type I interferon signaling pathway (GO:0060337) | 6.66716657 |
| 2 | * cellular response to type I interferon (GO:0071357) | 6.66716657 |
| 3 | * response to type I interferon (GO:0034340) | 6.60825663 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.49883895 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.45210747 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.27118468 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.14655063 |
| 8 | immunoglobulin mediated immune response (GO:0016064) | 5.00086426 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.97362861 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.93803810 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.93803810 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.87447126 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 4.87447126 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.87447126 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.87447126 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.87447126 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 4.87447126 |
| 18 | * response to interferon-alpha (GO:0035455) | 4.69314552 |
| 19 | response to interferon-beta (GO:0035456) | 4.66113546 |
| 20 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 4.60960223 |
| 21 | * negative regulation of viral genome replication (GO:0045071) | 4.59801143 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 4.46134993 |
| 23 | regulation of interferon-alpha production (GO:0032647) | 4.37855220 |
| 24 | detection of other organism (GO:0098543) | 4.37571187 |
| 25 | positive regulation of interferon-alpha production (GO:0032727) | 4.37530147 |
| 26 | detection of bacterium (GO:0016045) | 4.33068952 |
| 27 | response to peptidoglycan (GO:0032494) | 4.27998736 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.22108161 |
| 29 | negative regulation of interleukin-12 production (GO:0032695) | 4.19527906 |
| 30 | B cell mediated immunity (GO:0019724) | 3.96511832 |
| 31 | neutrophil activation involved in immune response (GO:0002283) | 3.79834123 |
| 32 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.77375487 |
| 33 | positive regulation of type 2 immune response (GO:0002830) | 3.77374110 |
| 34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.76214019 |
| 35 | response to host immune response (GO:0052572) | 3.76214019 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.71822706 |
| 37 | detection of external biotic stimulus (GO:0098581) | 3.68513554 |
| 38 | T cell migration (GO:0072678) | 3.66608509 |
| 39 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.64649653 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.56576780 |
| 41 | negative regulation of T cell mediated immunity (GO:0002710) | 3.56105846 |
| 42 | cellular response to interferon-beta (GO:0035458) | 3.53895725 |
| 43 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.52600474 |
| 44 | * cellular response to interferon-gamma (GO:0071346) | 3.52414486 |
| 45 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.47124095 |
| 46 | * defense response to virus (GO:0051607) | 3.46292014 |
| 47 | detection of molecule of bacterial origin (GO:0032490) | 3.44532105 |
| 48 | response to host (GO:0075136) | 3.44240649 |
| 49 | response to host defenses (GO:0052200) | 3.44240649 |
| 50 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.44240649 |
| 51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.43531231 |
| 52 | regulation of antigen processing and presentation (GO:0002577) | 3.40542059 |
| 53 | positive regulation of antigen processing and presentation (GO:0002579) | 3.40481463 |
| 54 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.37456760 |
| 55 | defense response to protozoan (GO:0042832) | 3.36330549 |
| 56 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.35476285 |
| 57 | * response to interferon-gamma (GO:0034341) | 3.34482939 |
| 58 | positive regulation of interferon-beta production (GO:0032728) | 3.34235829 |
| 59 | cellular response to exogenous dsRNA (GO:0071360) | 3.32932585 |
| 60 | NIK/NF-kappaB signaling (GO:0038061) | 3.25242207 |
| 61 | regulation of T cell tolerance induction (GO:0002664) | 3.24100138 |
| 62 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.23300392 |
| 63 | regulation of type 2 immune response (GO:0002828) | 3.22133689 |
| 64 | detection of biotic stimulus (GO:0009595) | 3.19267681 |
| 65 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.17526339 |
| 66 | microglial cell activation (GO:0001774) | 3.16706024 |
| 67 | * regulation of viral genome replication (GO:0045069) | 3.15811307 |
| 68 | germinal center formation (GO:0002467) | 3.13888457 |
| 69 | T-helper 1 type immune response (GO:0042088) | 3.13340733 |
| 70 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.12798675 |
| 71 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.12227752 |
| 72 | response to protozoan (GO:0001562) | 3.12221284 |
| 73 | negative regulation of innate immune response (GO:0045824) | 3.11692614 |
| 74 | cellular response to virus (GO:0098586) | 3.10748985 |
| 75 | myeloid cell activation involved in immune response (GO:0002275) | 3.10396852 |
| 76 | myeloid dendritic cell differentiation (GO:0043011) | 3.06750706 |
| 77 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.02377350 |
| 78 | * negative regulation of viral process (GO:0048525) | 3.02374676 |
| 79 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.01730667 |
| 80 | leukocyte aggregation (GO:0070486) | 3.00102782 |
| 81 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.98081158 |
| 82 | * cellular response to interferon-alpha (GO:0035457) | 2.97635713 |
| 83 | B cell receptor signaling pathway (GO:0050853) | 2.95534414 |
| 84 | regulation of tolerance induction (GO:0002643) | 2.95409400 |
| 85 | interferon-gamma secretion (GO:0072643) | 2.94414235 |
| 86 | myeloid dendritic cell activation (GO:0001773) | 2.92793587 |
| 87 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.90943588 |
| 88 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.89751724 |
| 89 | response to interleukin-15 (GO:0070672) | 2.89750432 |
| 90 | regulation of interferon-beta production (GO:0032648) | 2.89302319 |
| 91 | neutrophil activation (GO:0042119) | 2.88582387 |
| 92 | negative thymic T cell selection (GO:0045060) | 2.88290464 |
| 93 | respiratory burst (GO:0045730) | 2.87685445 |
| 94 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.87577071 |
| 95 | lymphocyte chemotaxis (GO:0048247) | 2.86099785 |
| 96 | macrophage activation (GO:0042116) | 2.83787685 |
| 97 | response to muramyl dipeptide (GO:0032495) | 2.83122079 |
| 98 | granulocyte activation (GO:0036230) | 2.82102096 |
| 99 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.81648921 |
| 100 | regulation of interleukin-12 production (GO:0032655) | 2.81354831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.43125377 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.70750744 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.05661000 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.24615514 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.20916672 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.53808676 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.28138876 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.24938263 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.02616807 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.97573689 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.84734765 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.70058616 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67982605 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57428636 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.53464157 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.34772721 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32853731 |
| 18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.23774937 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.18123279 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.14529054 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.13795834 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.13481737 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.10562010 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05340705 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.03011016 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.02155848 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 1.94705418 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91403632 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 1.84409816 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84407116 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78068805 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.76222838 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75271273 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 1.70461668 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65269351 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.63887677 |
| 37 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.63111806 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.60576608 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.54327530 |
| 40 | MAF_26560356_Chip-Seq_TH2_Human | 1.48913369 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48380791 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48109874 |
| 43 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.47944384 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40957550 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40135651 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39213732 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38382411 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32943669 |
| 49 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.32899838 |
| 50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32316377 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32098242 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31158239 |
| 53 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27900112 |
| 54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27057187 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26348870 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23560981 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19775473 |
| 58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18600076 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18289735 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17743172 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15761521 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15477481 |
| 63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14348580 |
| 64 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13825344 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13087975 |
| 66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11806432 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10605316 |
| 68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10387410 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09989364 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09166116 |
| 71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08355001 |
| 72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08110438 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06837561 |
| 74 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.06483680 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04896401 |
| 76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01143671 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00154442 |
| 78 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98655734 |
| 79 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.98470857 |
| 80 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98418373 |
| 81 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96461186 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96261110 |
| 83 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93514412 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90102957 |
| 85 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.89863728 |
| 86 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.89165075 |
| 87 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.84486928 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84109081 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83953564 |
| 90 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.83899998 |
| 91 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82796286 |
| 92 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79237592 |
| 93 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.78874124 |
| 94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76000960 |
| 95 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74971691 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.74890496 |
| 97 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.71199155 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.71026961 |
| 99 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.69047296 |
| 100 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.68089402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.59480157 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.55634227 |
| 3 | MP0003303_peritoneal_inflammation | 4.01781490 |
| 4 | MP0009785_altered_susceptibility_to | 3.72059237 |
| 5 | MP0003436_decreased_susceptibility_to | 3.57186923 |
| 6 | MP0005671_abnormal_response_to | 3.31992185 |
| 7 | MP0001790_abnormal_immune_system | 3.25450493 |
| 8 | MP0005387_immune_system_phenotype | 3.25450493 |
| 9 | MP0006082_CNS_inflammation | 3.24814792 |
| 10 | MP0005000_abnormal_immune_tolerance | 3.12021330 |
| 11 | MP0001800_abnormal_humoral_immune | 3.10403578 |
| 12 | MP0005025_abnormal_response_to | 3.05913462 |
| 13 | MP0000685_abnormal_immune_system | 3.05429026 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.97060428 |
| 15 | MP0002419_abnormal_innate_immunity | 2.77785821 |
| 16 | MP0002723_abnormal_immune_serum | 2.72239696 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.67520673 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.39741909 |
| 19 | MP0001819_abnormal_immune_cell | 2.39268845 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.27676612 |
| 21 | MP0010155_abnormal_intestine_physiology | 2.21794548 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.00171713 |
| 23 | MP0001845_abnormal_inflammatory_respons | 1.98421709 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 1.91064059 |
| 25 | MP0003763_abnormal_thymus_physiology | 1.90575731 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.89087387 |
| 27 | MP0004947_skin_inflammation | 1.83584059 |
| 28 | MP0000716_abnormal_immune_system | 1.82570510 |
| 29 | MP0009764_decreased_sensitivity_to | 1.78826112 |
| 30 | MP0002405_respiratory_system_inflammati | 1.77906471 |
| 31 | MP0008469_abnormal_protein_level | 1.76727533 |
| 32 | MP0002398_abnormal_bone_marrow | 1.73593433 |
| 33 | MP0004510_myositis | 1.63206810 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.62533331 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.59437368 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.51649076 |
| 37 | MP0005310_abnormal_salivary_gland | 1.51052608 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.50558290 |
| 39 | MP0003075_altered_response_to | 1.46646703 |
| 40 | MP0005451_abnormal_body_composition | 1.45311949 |
| 41 | MP0003866_abnormal_defecation | 1.44861202 |
| 42 | MP0002429_abnormal_blood_cell | 1.43091719 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.42683006 |
| 44 | MP0002722_abnormal_immune_system | 1.34295556 |
| 45 | MP0000858_altered_metastatic_potential | 1.34278604 |
| 46 | MP0000343_altered_response_to | 1.33439061 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.33148474 |
| 48 | MP0003806_abnormal_nucleotide_metabolis | 1.32201844 |
| 49 | MP0002139_abnormal_hepatobiliary_system | 1.31957372 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.31419204 |
| 51 | MP0009840_abnormal_foam_cell | 1.30560956 |
| 52 | MP0005166_decreased_susceptibility_to | 1.27370690 |
| 53 | MP0001853_heart_inflammation | 1.25952833 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.22611226 |
| 55 | MP0008260_abnormal_autophagy | 1.21501947 |
| 56 | MP0009278_abnormal_bone_marrow | 1.20732581 |
| 57 | MP0002006_tumorigenesis | 1.19921607 |
| 58 | MP0001873_stomach_inflammation | 1.17624746 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.16961097 |
| 60 | MP0009763_increased_sensitivity_to | 1.07361727 |
| 61 | MP0003448_altered_tumor_morphology | 1.05664667 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.03117552 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.03117552 |
| 64 | MP0004883_abnormal_blood_vessel | 1.02286694 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.01061616 |
| 66 | MP0000703_abnormal_thymus_morphology | 0.99668778 |
| 67 | MP0002132_abnormal_respiratory_system | 0.98959459 |
| 68 | MP0005164_abnormal_response_to | 0.96687764 |
| 69 | MP0000604_amyloidosis | 0.94624728 |
| 70 | MP0003045_fibrosis | 0.93279982 |
| 71 | MP0001663_abnormal_digestive_system | 0.90600828 |
| 72 | MP0003690_abnormal_glial_cell | 0.87926606 |
| 73 | MP0003828_pulmonary_edema | 0.84994513 |
| 74 | MP0008004_abnormal_stomach_pH | 0.84189979 |
| 75 | MP0005390_skeleton_phenotype | 0.80963915 |
| 76 | MP0002332_abnormal_exercise_endurance | 0.80649472 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 0.76523243 |
| 78 | MP0001851_eye_inflammation | 0.75745505 |
| 79 | MP0002933_joint_inflammation | 0.75358538 |
| 80 | MP0000490_abnormal_crypts_of | 0.74911778 |
| 81 | MP0002396_abnormal_hematopoietic_system | 0.69926351 |
| 82 | MP0008874_decreased_physiological_sensi | 0.69498836 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.68369505 |
| 84 | MP0004808_abnormal_hematopoietic_stem | 0.66816267 |
| 85 | MP0000249_abnormal_blood_vessel | 0.66081181 |
| 86 | MP0004381_abnormal_hair_follicle | 0.66072054 |
| 87 | MP0003091_abnormal_cell_migration | 0.65867944 |
| 88 | MP0000609_abnormal_liver_physiology | 0.65462578 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.61422741 |
| 90 | MP0003795_abnormal_bone_structure | 0.60899725 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 0.59236360 |
| 92 | MP0002693_abnormal_pancreas_physiology | 0.58502489 |
| 93 | MP0005165_increased_susceptibility_to | 0.57518505 |
| 94 | MP0002254_reproductive_system_inflammat | 0.54949937 |
| 95 | MP0006054_spinal_hemorrhage | 0.52499292 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.52058726 |
| 97 | MP0005381_digestive/alimentary_phenotyp | 0.51715920 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.50923341 |
| 99 | MP0000920_abnormal_myelination | 0.50121255 |
| 100 | MP0003252_abnormal_bile_duct | 0.47304700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.73362122 |
| 2 | Orchitis (HP:0100796) | 5.19454673 |
| 3 | Optic neuritis (HP:0100653) | 5.11896978 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 5.11896978 |
| 5 | Myositis (HP:0100614) | 5.11068799 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 5.10020985 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.94665908 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.88880740 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.38700091 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.29155036 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.09184466 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.07196671 |
| 13 | Vasculitis (HP:0002633) | 4.03531195 |
| 14 | Meningitis (HP:0001287) | 4.01859201 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 3.94291008 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.94291008 |
| 17 | Stomatitis (HP:0010280) | 3.90308131 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 3.82150967 |
| 19 | Recurrent skin infections (HP:0001581) | 3.73505741 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.72221802 |
| 21 | Keratoconjunctivitis sicca (HP:0001097) | 3.60875725 |
| 22 | Recurrent viral infections (HP:0004429) | 3.60435427 |
| 23 | Pulmonary infiltrates (HP:0002113) | 3.56800975 |
| 24 | Increased IgM level (HP:0003496) | 3.51797086 |
| 25 | Encephalitis (HP:0002383) | 3.44118979 |
| 26 | Obstructive lung disease (HP:0006536) | 3.39989470 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.39989470 |
| 28 | Keratoconjunctivitis (HP:0001096) | 3.34916833 |
| 29 | Hemoptysis (HP:0002105) | 3.33779723 |
| 30 | Increased IgE level (HP:0003212) | 3.28233269 |
| 31 | Urticaria (HP:0001025) | 3.26841494 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 3.21029543 |
| 33 | Recurrent bronchitis (HP:0002837) | 3.16602985 |
| 34 | Gingivitis (HP:0000230) | 3.12453336 |
| 35 | Abnormality of glycolipid metabolism (HP:0010969) | 3.11962006 |
| 36 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.11962006 |
| 37 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.11962006 |
| 38 | Agammaglobulinemia (HP:0004432) | 3.03334409 |
| 39 | Cellulitis (HP:0100658) | 2.96748178 |
| 40 | Chronic otitis media (HP:0000389) | 2.94891459 |
| 41 | Loss of speech (HP:0002371) | 2.92876379 |
| 42 | Spontaneous hematomas (HP:0007420) | 2.92278833 |
| 43 | Hypergammaglobulinemia (HP:0010702) | 2.90641977 |
| 44 | Abnormality of T cell number (HP:0011839) | 2.86826793 |
| 45 | Gastrointestinal stroma tumor (HP:0100723) | 2.80742920 |
| 46 | Autoimmune hemolytic anemia (HP:0001890) | 2.78802026 |
| 47 | Arterial thrombosis (HP:0004420) | 2.77811088 |
| 48 | T lymphocytopenia (HP:0005403) | 2.77007240 |
| 49 | Colitis (HP:0002583) | 2.75369139 |
| 50 | Chest pain (HP:0100749) | 2.70905755 |
| 51 | Gangrene (HP:0100758) | 2.68920970 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.68872901 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 2.66004660 |
| 54 | Abnormality of the pleura (HP:0002103) | 2.61774891 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.57529006 |
| 56 | Petechiae (HP:0000967) | 2.57494787 |
| 57 | Anorexia (HP:0002039) | 2.57322101 |
| 58 | Abnormality of T cells (HP:0002843) | 2.57078796 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.56622933 |
| 60 | Gingival bleeding (HP:0000225) | 2.54498727 |
| 61 | Osteomyelitis (HP:0002754) | 2.54077117 |
| 62 | Pulmonary embolism (HP:0002204) | 2.50224430 |
| 63 | Leukocytosis (HP:0001974) | 2.49836755 |
| 64 | Pustule (HP:0200039) | 2.43986739 |
| 65 | Lymphopenia (HP:0001888) | 2.40512006 |
| 66 | Abnormality of T cell physiology (HP:0011840) | 2.38950017 |
| 67 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.36531504 |
| 68 | Granulocytopenia (HP:0001913) | 2.32616779 |
| 69 | Purpura (HP:0000979) | 2.32515352 |
| 70 | Recurrent pneumonia (HP:0006532) | 2.31746038 |
| 71 | Nasal polyposis (HP:0100582) | 2.30077429 |
| 72 | Hypochromic anemia (HP:0001931) | 2.29471189 |
| 73 | Skin rash (HP:0000988) | 2.26746204 |
| 74 | Amyloidosis (HP:0011034) | 2.25644383 |
| 75 | Malnutrition (HP:0004395) | 2.23263590 |
| 76 | Skin ulcer (HP:0200042) | 2.23248474 |
| 77 | Epistaxis (HP:0000421) | 2.23006771 |
| 78 | Cheilitis (HP:0100825) | 2.22664870 |
| 79 | Sepsis (HP:0100806) | 2.21878994 |
| 80 | Chronic diarrhea (HP:0002028) | 2.21619022 |
| 81 | Increased cerebral lipofuscin (HP:0011813) | 2.21229060 |
| 82 | Dysostosis multiplex (HP:0000943) | 2.18539036 |
| 83 | Abnormality of the endocardium (HP:0004306) | 2.17529364 |
| 84 | IgM deficiency (HP:0002850) | 2.16844358 |
| 85 | Recurrent sinusitis (HP:0011108) | 2.16682199 |
| 86 | Abnormality of the pericardium (HP:0001697) | 2.15762298 |
| 87 | Abnormality of the nasal mucosa (HP:0000433) | 2.13793469 |
| 88 | Eosinophilia (HP:0001880) | 2.13137045 |
| 89 | IgG deficiency (HP:0004315) | 2.12848083 |
| 90 | Premature loss of primary teeth (HP:0006323) | 2.12576401 |
| 91 | Polyneuropathy (HP:0001271) | 2.11354604 |
| 92 | Abnormality of B cell number (HP:0010975) | 2.11127561 |
| 93 | Recurrent lower respiratory tract infections (HP:0002783) | 2.10469388 |
| 94 | Peritonitis (HP:0002586) | 2.10128733 |
| 95 | Emphysema (HP:0002097) | 2.09808979 |
| 96 | Glomerulopathy (HP:0100820) | 2.09805261 |
| 97 | Joint swelling (HP:0001386) | 2.09764942 |
| 98 | Episodic fever (HP:0001954) | 2.09686577 |
| 99 | Abnormality of the peritoneum (HP:0002585) | 2.09608916 |
| 100 | Vacuolated lymphocytes (HP:0001922) | 2.09168486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.29618664 |
| 2 | TYK2 | 4.06560160 |
| 3 | MAP4K1 | 3.92761070 |
| 4 | IKBKE | 3.14118820 |
| 5 | BLK | 2.99192184 |
| 6 | IRAK4 | 2.96802632 |
| 7 | ERN1 | 2.92786388 |
| 8 | JAK3 | 2.74856409 |
| 9 | MAP3K14 | 2.73735673 |
| 10 | TBK1 | 2.63757734 |
| 11 | JAK1 | 2.55219162 |
| 12 | FGFR4 | 2.47008191 |
| 13 | KIT | 2.38483939 |
| 14 | PRPF4B | 2.23274405 |
| 15 | CSK | 2.19200226 |
| 16 | MAP3K13 | 1.92315496 |
| 17 | TXK | 1.80907255 |
| 18 | SYK | 1.67959949 |
| 19 | IRAK3 | 1.67281954 |
| 20 | MAP2K3 | 1.63801860 |
| 21 | IKBKB | 1.62643426 |
| 22 | ZAP70 | 1.62238826 |
| 23 | FGFR3 | 1.58732908 |
| 24 | BTK | 1.57734219 |
| 25 | MATK | 1.57646224 |
| 26 | CSF1R | 1.55857367 |
| 27 | BMPR2 | 1.51146829 |
| 28 | FGR | 1.49980811 |
| 29 | FES | 1.44634279 |
| 30 | TNK2 | 1.42791139 |
| 31 | EPHB1 | 1.40912808 |
| 32 | LYN | 1.39274067 |
| 33 | MAP3K3 | 1.38606373 |
| 34 | GRK7 | 1.37375858 |
| 35 | JAK2 | 1.35735879 |
| 36 | HCK | 1.25174426 |
| 37 | GRK6 | 1.16541120 |
| 38 | TAOK1 | 1.16214565 |
| 39 | LCK | 1.16125261 |
| 40 | MAP3K11 | 1.15715524 |
| 41 | TESK2 | 1.12609652 |
| 42 | TAOK2 | 1.12522815 |
| 43 | SIK3 | 1.10898825 |
| 44 | TAOK3 | 1.01041006 |
| 45 | RIPK1 | 1.00028528 |
| 46 | ITK | 0.98258509 |
| 47 | CDC42BPA | 0.96640245 |
| 48 | IRAK1 | 0.95080984 |
| 49 | MAP3K1 | 0.92387619 |
| 50 | NME2 | 0.91711611 |
| 51 | MAPK11 | 0.84634639 |
| 52 | STK10 | 0.83735368 |
| 53 | MARK3 | 0.80059941 |
| 54 | TEC | 0.78222874 |
| 55 | EPHA3 | 0.74034206 |
| 56 | CHUK | 0.72055367 |
| 57 | PDK1 | 0.71008518 |
| 58 | TGFBR2 | 0.64331764 |
| 59 | SIK2 | 0.64033777 |
| 60 | PRKCQ | 0.62912143 |
| 61 | HIPK2 | 0.62802434 |
| 62 | MAPK7 | 0.60901079 |
| 63 | YES1 | 0.58524874 |
| 64 | TRIB3 | 0.58190262 |
| 65 | PDPK1 | 0.56989627 |
| 66 | IRAK2 | 0.56859306 |
| 67 | DDR2 | 0.52140273 |
| 68 | MOS | 0.50803104 |
| 69 | PIM2 | 0.49788861 |
| 70 | SMG1 | 0.49113981 |
| 71 | LRRK2 | 0.49019375 |
| 72 | PIM1 | 0.45907755 |
| 73 | MAP3K5 | 0.45680901 |
| 74 | PRKD2 | 0.45174695 |
| 75 | ADRBK2 | 0.44820366 |
| 76 | FYN | 0.44491543 |
| 77 | ARAF | 0.42307189 |
| 78 | ACVR1B | 0.41954051 |
| 79 | KSR2 | 0.41115984 |
| 80 | SIK1 | 0.39311159 |
| 81 | PRKCD | 0.38841288 |
| 82 | MAPKAPK2 | 0.36770778 |
| 83 | PTK6 | 0.35999604 |
| 84 | NLK | 0.35561284 |
| 85 | MAP2K6 | 0.34114585 |
| 86 | NEK9 | 0.34017200 |
| 87 | BMX | 0.33254707 |
| 88 | MAPK12 | 0.30569370 |
| 89 | ABL1 | 0.30277579 |
| 90 | PIK3CG | 0.25556964 |
| 91 | TLK1 | 0.25156714 |
| 92 | MARK2 | 0.22549916 |
| 93 | RPS6KA5 | 0.22341588 |
| 94 | MST1R | 0.22124001 |
| 95 | CDK4 | 0.20419132 |
| 96 | PTK2B | 0.19954848 |
| 97 | CAMKK2 | 0.19548164 |
| 98 | STK24 | 0.19104432 |
| 99 | MAP3K6 | 0.18616772 |
| 100 | MAPK4 | 0.18543238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.70525340 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.42126057 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.35927473 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.02335975 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.01759821 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 3.00830862 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.89904619 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.68530345 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.60129983 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.52890484 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.45856164 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.41110271 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.37978828 |
| 14 | * Measles_Homo sapiens_hsa05162 | 2.25778957 |
| 15 | * Influenza A_Homo sapiens_hsa05164 | 2.25042709 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.23114166 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.12986122 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 2.06450732 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.99062605 |
| 20 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.97692704 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.96427914 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.88529877 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.76658858 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70653614 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.69273021 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61304769 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.60894540 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60499474 |
| 29 | * Hepatitis C_Homo sapiens_hsa05160 | 1.56122992 |
| 30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.49065974 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47737376 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.39716979 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.39162998 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33467674 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.31952322 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31941840 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.26664251 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.25671255 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.19440281 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16988667 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.16453950 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.11965467 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10481293 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02270011 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98066933 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 0.93103702 |
| 47 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91032143 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.90286585 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 0.87473017 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84780812 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81626614 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.76995388 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64668461 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63586687 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61429988 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59921224 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55456726 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50925341 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50674514 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.48838184 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48304474 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46764812 |
| 63 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46491797 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46384837 |
| 65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41584369 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36779069 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36774126 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.36048766 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34096989 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.32512690 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31661879 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.31653408 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30860894 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.28351279 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27939168 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.27255910 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26924410 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24401675 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22859850 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.21874089 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21532033 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18044141 |
| 83 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.17728909 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17582270 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.17202240 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16209505 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15729866 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.15537833 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.14712038 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.14514768 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.12747209 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.11136026 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.10879235 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.10783903 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.09444827 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.09429851 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.09039188 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.08479744 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.05690790 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.05179283 |

